Top Tweets for #Exon14
🔹#RespirologyCaseReports
#Mesenchymal-epithelial transition factor #exon14 skipping mutation-positive granulocyte colony-stimulating factor-producing lung #adenocarcinoma mimicking lung abscess: A case report
https://t.co/SmIrGTncUL
Great news for #NSCLC #MET #exon14 patients in the treatment-naive setting. All the more reason for molecular profiling labs to introduce the patient and ordering oncologist to the relevant biomarker support groups when the molecular diagnosis is first understood. Labs in the U.S. and around the world, please help us get that underway!
A new trial activated at MDACC https://t.co/6GdxbO3ueS
A novel MET TKI (ABN401) for METex14 NSCLC pts. Preliminary efficacy ORR 75% in TKI-naive pts and very favorable toxicity profile. @LaurenByersMD @esinghimd @metcrusaders @Exon20Group
📢New published paper ''#MET Exon 14 Variants in Non-Small Cell #Lung Carcinoma: Prevalence, #Clinicopathologic and #Molecular Features''
📌Enjoy reading: https://t.co/BVUHvqrbxx
#exon14; #non_small_cell_lung_carcinoma #NSCLC
$JNJ Presents Ph1 Results for #RYBREVANT (#amivantamab) in the treatment of Advanced NSCLC with MET #Exon14 Skipping Mutations
"..data showing evidence that RYBREVANT can lead to #broad activity against both EGFR and MET-driven tumors." $GMAB #Genmab
https://t.co/uuCIO1Zz4V
Dr. Fernando Santini, oncologista clínico do Sírio Libanês, comenta aprovação do #capmatinibe - inibidor reversível, seletivo e específico para o MET #exon14. A nova terapia-alvo pode beneficiar quase 4% dos pacientes com #CPNPC não escamosos.
Saiba mais: https://t.co/0w6btTw4sT
Live #AACR20 Tweet @ivybelkins " Capmatinib in #MET #exon14 skipping mutation. Two cohorts -- treatment naive and pre-treated. Looks promising with respect to brain penetration" @OncoAlert 🚨 #LungCancer #LCSM
Edward Garon @UCLA presents on #capmatinib in #MET #exon14 skipping mutation. Two cohorts -- treatment naive and pre-treated. Looks promising with respect to brain penetration. #AACR20 #lungcancer #lcsm @EGFRResisters
Edward Garon @UCLA presents on #capmatinib in #MET #exon14 skipping mutation. Two cohorts -- treatment naive and pre-treated. Looks promising with respect to brain penetration. #AACR20 #lungcancer #lcsm @EGFRResisters
Our #ClinicalTrial is now enrolling #NSCLC patients with c-Met Exon 14 mutations. If you or someone you know might be eligible, please review the details here. #cMet #Exon14 #mutation #LungCancer
https://t.co/POurWJ77YU
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers